The store will not work correctly when cookies are disabled.
N1-(4-(2,4-dichlorophenyl)thiazol-2-yl)benzene-1,4-diamine
ID: ALA3618486
PubChem CID: 972510
Max Phase: Preclinical
Molecular Formula: C15H11Cl2N3S
Molecular Weight: 336.25
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1ccc(Nc2nc(-c3ccc(Cl)cc3Cl)cs2)cc1
Standard InChI: InChI=1S/C15H11Cl2N3S/c16-9-1-6-12(13(17)7-9)14-8-21-15(20-14)19-11-4-2-10(18)3-5-11/h1-8H,18H2,(H,19,20)
Standard InChI Key: RRIBPNBJIQVROP-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5972 -1.5031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5951 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8056 -3.8680 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-3.3371 -5.2929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8371 -5.2877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3786 -3.8595 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9508 -6.4988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5248 -6.2201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4993 -7.3604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9989 -8.7745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4759 -9.0482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4503 -7.9079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6303 -8.1265 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.7785 -9.6868 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.3383 1.3500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 8 2 0
11 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
18 19 1 0
16 20 1 0
2 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 336.25 | Molecular Weight (Monoisotopic): 335.0051 | AlogP: 5.44 | #Rotatable Bonds: 3 |
Polar Surface Area: 50.94 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 4.86 | CX LogP: 5.17 | CX LogD: 5.17 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.63 | Np Likeness Score: -1.97 |
References
1. Al-Asri J, Fazekas E, Lehoczki G, Perdih A, Görick C, Melzig MF, Gyémánt G, Wolber G, Mortier J.. (2015) From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors., 23 (20): [PMID:26395057] [10.1016/j.bmc.2015.09.007] |